Vanguard Capital Management
CNMD icon

Vanguard Capital Management’s CONMED CNMD Stock Holding History

Vanguard Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4M Sell
1,355,728
-28,314
-2% -$1.02M ﹤0.01% 2010
2026
Q1 		$48.9M Buy
+1,384,042
New +$56.3M ﹤0.01% 1861

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management's CNMD Position: Q2 2026 in Review

Vanguard Capital Management reduced its CONMED (CNMD) stake by 2% in Q2 2026, selling an estimated $1.02M and leaving 1,355,728 shares worth $44.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

Vanguard Capital Management first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $48.9M in Q1 2026. 244 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Vanguard Capital Management held 1,355,728 shares of CONMED worth $44.4M as of Q2 2026.
  • Vanguard Capital Management sold 28,314 CONMED shares in Q2 2026, an estimated $1.02M.
  • CONMED made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2010 holding.
  • Vanguard Capital Management first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's CONMED position peaked at $48.9M in Q1 2026.
  • 244 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.